A DAILY weight loss pill that helped patients shed up to 20 per cent of their body weight in trials has been given the green ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

A pill version of weight-loss drug Wegovy will be manufactured in the Triangle and could be available within weeks after the ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

The United States Food and Drug Administration (FDA) has approved a new oral version of the weight loss medication Wegovy, ...

Novo Nordisk said it expects the pill to be launched in the United States in early January starting at $149 a month for the ...

The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment cleared for use without injections.